Loading
Latest filing published 17 Feb 2022 for PROGENITY, INC., €314. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Hutan Hashemi discloses dealings in Biora Therapeutics, Inc. to SEC (Form 4). Between 15 May 2021 and 15 February 2022, the trades on record add up to 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 17 February 2022, reports a share grant of €314 in Biora Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations